OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A DNA/DMXAA/Metal–Organic Framework Activator of Innate Immunity for Boosting Anticancer Immunity
Xiaojing Chen, Qianyun Tang, Jinqiang Wang, et al.
Advanced Materials (2023), pp. 2210440-2210440
Closed Access | Times Cited: 50

Showing 26-50 of 50 citing articles:

Platelet hitchhiking vascular-disrupting agents for self-amplified tumor-targeting therapy
Hongyu Chu, Yajun Xu, Yuezhan Shan, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access

Breaking the barriers in effective and safe toll-like receptor stimulation via nano-immunomodulators for potent cancer immunotherapy
Yaoqi Li, Yitian Chen, Yongan Tang, et al.
Journal of Controlled Release (2025), pp. 113667-113667
Closed Access

Polysaccharide nanoadjuvants with precise drug composition for enhanced STING-mediated APC activation
Jingxuan Ju, Danni Xu, Li Xu, et al.
European Polymer Journal (2024) Vol. 217, pp. 113333-113333
Closed Access | Times Cited: 3

Empowering radiotherapy: Harnessing nanomedicines to enhance radiation response and boost antitumor efficacy
Xiqian Zhuo, Reyida Aishajiang, Liang Yuan, et al.
Coordination Chemistry Reviews (2024) Vol. 520, pp. 216140-216140
Closed Access | Times Cited: 3

Triple-pathway cGAS-STING activation collaborated with ferroptosis-induced immunogenic cell death for boosting systemic colorectal cancer immunotherapy
Shaopeng Zhang, Hao Zhang, Yue Cao, et al.
Nano Today (2024) Vol. 59, pp. 102484-102484
Closed Access | Times Cited: 3

Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments
Wenya Li, G Chen, Hailin Peng, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1161-1161
Open Access | Times Cited: 3

Engineering hierarchical metal-organic@metal-DNA heterostructures for combinational tumor treatment
Xueyan Feng, Bei Liu, Zehao Zhou, et al.
Nano Research (2023) Vol. 16, Iss. 11, pp. 12633-12640
Closed Access | Times Cited: 8

Smart Tumor Cell‐Derived DNA Nano‐Tree Assembly for On‐Demand Macrophages Reprogramming
Zhiguo Chen, Sha Yang, Zhuyang Zhao, et al.
Advanced Science (2023) Vol. 11, Iss. 10
Open Access | Times Cited: 8

Mechanism of action and treatment of type I interferon in hepatocellular carcinoma
Chunxiu Peng, Zhijian Ye, Ying Ju, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 2, pp. 326-337
Closed Access | Times Cited: 7

Tumor vasculature associated nanomedicine strategies
Xiaorui Wang, Xuejiao Song, Qinglin Wei, et al.
Coordination Chemistry Reviews (2024) Vol. 521, pp. 216189-216189
Closed Access | Times Cited: 2

Chemical Biology Perspectives on STING Agonists as Tumor Immunotherapy
Chenyuan Xuan, Rong Hu
ChemMedChem (2023) Vol. 18, Iss. 23
Open Access | Times Cited: 6

Tetrahedral DNA nanostructure enhanced toehold-mediated strand displacement for highly sensitive electrochemiluminescence assay of CA125
Weiwei Zhang, Wenwen Wang, Yueyue Yu
Bioelectrochemistry (2023) Vol. 155, pp. 108572-108572
Closed Access | Times Cited: 4

A dual-targeted small-molecule photosensitizer with enhanced dual antitumor and anti-vascular effect for metastatic advanced prostate cancer photodynamic therapy
Juanjuan Chen, Jiaqi Xu, Qilu Wang, et al.
Dyes and Pigments (2024), pp. 112476-112476
Closed Access | Times Cited: 1

Nanomaterial-assisted delivery of CpG oligodeoxynucleotides for boosting cancer immunotherapy
Zhiyu Zhang, Lu Yu, Wenjing Liu, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 184-199
Closed Access | Times Cited: 1

Proteomics efforts for hepatocellular carcinoma drug development
Dongling Jia, Zefei Jiang, Minhui Cui, et al.
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1

Nanocarrier design for pathogen-inspired innate immune agonist delivery
Griffin Kane, Meghan L. Brassil, Miranda Diaz-Infante, et al.
Trends in Immunology (2024) Vol. 45, Iss. 9, pp. 678-692
Open Access

The β-glucan nanotube carrier achieves detoxification and efficacy enhancement of celastrol in intrahepatic cholangiocarcinoma therapy by increasing targeted controlled release and macrophage polarization
Zihan He, Zhangwei Yang, Mingjie Hu, et al.
International Journal of Biological Macromolecules (2024) Vol. 280, pp. 135848-135848
Closed Access

Recent advances in nanoadjuvant-triggered STING activation for enhanced cancer immunotherapy
Z Y Xu, Yi-Hong Wu, Junjie Hu, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e38900-e38900
Open Access

Metal‐organic frameworks‐based nanomedicines to promote cancer immunotherapy: Recent advances and future directions
Chenqian Feng, Xiaoyan Liang, Rangrang Fan, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 4
Open Access

Nanotechnology based approaches for leukemia therapy

Biomedical Letters (2024) Vol. 10, Iss. 2, pp. 90-103
Closed Access

Harnessing biomaterial architecture to drive anticancer innate immunity
Meredith A. Davis, Ezra Cho, Michelle H. Teplensky
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 46, pp. 10982-11005
Closed Access | Times Cited: 1

Tungsten-based nanoparticles as contrast agents for liver tumor detection using dual-energy computed tomography
Xiuru Ji, Lan Zhu, Jessica C. Hsu, et al.
Biomaterials Science (2023) Vol. 11, Iss. 24, pp. 7817-7825
Closed Access

Previous Page - Page 2

Scroll to top